等待开盘 03-26 09:30:00 美东时间
0.000
0.00%
BRIEF-FDA Approves Relacorilant With NAB-Paclitaxel For Platinum-Resistant Epithelial Ovarian, Fallopian Tube,Primary Peritoneal Cancer March 25 (Reuters) - US FDA: FDA APPROVES RELACORILANT WITH NAB-PACLITAXEL FOR PLATINUM-RESISTANT EPITHELIAL OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER F
03-25 22:59
BRIEF-American Express Launches New Graphite Business Cash Unlimited Card March 25 (Reuters) - American Express Co AXP.N : AMERICAN EXPRESS: LAUNCHES NEW GRAPHITE BUSINESS CASH UNLIMITED CARD AMERICAN EXPRESS: BUSINESS MEMBERSHIP TO EXPAND WITH EIGHT NEW PRODUCTS, BENEFITS, AI-POWERED CAPABILITIES F
03-25 19:00
BRIEF-Eli Lilly's Retatrutide Showed Significant Reductions In A1C & Weight In TRANSCEND-T2D-1 Trial March 19 (Reuters) - Eli Lilly and Co LLY.N : ELI LILLY: RETATRUTIDE SHOWED SIGNIFICANT REDUCTIONS IN A1C & WEIGHT IN FIRST PHASE 3 TRIAL FOR TYPE 2 DIABETES TREATMENT ELI LILLY: RETATRUTIDE LOWERED
03-19 18:45
Platinum Industries Limited ( ($IN:PLATIND) ) has shared an update. Platinum In...
03-11 20:39
BRIEF-Reliance Subsidiary AMI Metals Awarded Significant Government Infrastructure And Defense Projects March 10 (Reuters) - Reliance Inc RS.N : RELIANCE, INC. SUBSIDIARY AMI METALS, INC. AWARDED SIGNIFICANT GOVERNMENT INFRASTRUCTURE AND DEFENSE PROJECTS RELIANCE INC - AMI METALS AWARDED MULTI-YEAR
03-10 18:53
Platinum Industries Limited ( ($IN:PLATIND) ) has issued an announcement. Plati...
03-04 00:49
Veru Inc. Publishes Corporate Presentation on Enobosarm-GLP-1 Obesity Program and Sabizabulin Atherosclerosis Development Veru Inc. outlined its cardiometabolic pipeline, highlighting enobosarm, an oral selective androgen receptor modulator, being developed in combination with a GLP-1 receptor agoni
03-02 22:39
BRIEF-Kraken Announces Payward Acquires Magna Feb 18 (Reuters) - Kraken: KRAKEN: ANNOUNCE THAT PAYWARD, CO'S UNIFIED FINANCIAL INFRASTRUCTURE PLATFORM POWERING KRAKEN, HAS ACQUIRED MAGNA KRAKEN: TERMS OF THE TRANSACTION WILL NOT BE DISCLOSED KRAKEN: MAGNA WILL CONTINUE OPERATING AS A STANDALONE PLAT
02-19 01:44
BRIEF-Hoth Therapeutics Announces Groundbreaking Positive Results Hoth's Ht-Va Gdnf Surpasses Semaglutide In Weight Loss Feb 10 (Reuters) - Hoth Therapeutics Inc HOTH.O : HOTH THERAPEUTICS ANNOUNCES GROUNDBREAKING POSITIVE RESULTS: HOTH'S HT-VA GDNF SURPASSES SEMAGLUTIDE IN WEIGHT LOSS, GLUCOSE CONT
02-10 21:42
Med crude-Urals diffs stable as February cargoes clear slowly MOSCOW, Jan 29 (Reuters) - Urals crude differentials to dated Brent were stable on Thursday in quiet trade while February cargoes were slow to clear, traders said. India is expected to increase buying of February Urals compared to January
01-30 00:25